Victor Shi Chenyang
- President, Asia-Pacific, QIAGEN, People's Republic of China
BSc, University of Science and Technology, China; MSc and PhD, University of Rochester. Over 20 years' experience in life science business development, management and investment. Formerly with: Aura Partners; Bridge Pharmaceuticals; Discovery Resources Group; Genospectra; AM Pappas & Associates; National Univ. of Singapore School of Medicine; Merck & Co. Currently President, Asia-Pacific, QIAGEN, heads commercial operations and strategic development in Asia and manages an organization with over 600 employees in 11 subsidiaries. Deputy Secretary-General, Professional Committee of Chinese In-vitro Diagnostics Industry Association.